Switch from Intravitreal Ranibizumab to Bevacizumab for the Treatment of Neovascular Age-Related Macular Degeneration: Clinical Comparison
AuthID
P-00A-0B0
P-00A-0B0
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service